AKT1 and colorectal cancer: Butyrate was shown to suppress colorectal cancer cell motility by inhibiting HDAC activity and decreasing phosphorylation of Akt1 and ERK1/2 (Li et al. 2017), suggesting a similar mechanism is involved in HGF.